Refine by
Health Protection Program Articles & Analysis
124 news found
Closing follows announcement of acquisition on January 18, 2023 Acquisition bolsters Bayer’s position in digital medical imaging Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer today announced that the company has completed the acquisition of the global strategic ...
ByBayer AG
Acquisition is part of Bayer’s innovation strategy in radiology Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology Following closing of the acquisition, Blackford Analysis to become part of Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer today ...
ByBayer AG
Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that ApolloMed received certification from the National Committee for Quality Assurance ("NCQA") for ...
The 101 Corridor is leading the way in new diagnostics that will bring information to you and your doctor within minutes or hours. You will no longer have to wait for days for a central diagnostic laboratory to provide critical medical test data regarding your health. This program showcases a range of young diagnostic companies that are poised to launch exciting products and services that will ...
Today we’d like to introduce you to Gillian Henker. Hi Gillian, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today. In 2014, Gillian Henker co-founded Sisu Global, leading the company’s products and technical strategy. Henker is the primary inventor of Hemafuse ...
” A free, online version of the publication – “Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice” – is available on NPJ Vaccines here. (DOI: 10.1038/s41541-022-00534-5) The NIH has renewed funding for the research program as a Phase ...
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) today announced new analyses from across the development program for zuranolone, an investigational, oral, once-daily, 14-day treatment in clinical development for adult patients with major depressive disorder (MDD) and postpartum depression. The 11 new analyses are being presented at the 2022 Psych Congress in New Orleans, ...
Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
PatientPoint today announced that it will be supporting the Susan G. Komen®Stand for H.E.R—a Health Equity Revolution program by bringing point-of-care breast health resources to patients and healthcare providers in U.S. metropolitan areas where breast cancer mortality gaps are greatest between Black and white women. Now through the end of 2022, PatientPoint will promote Komen content ...
Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB). Soistman is an accomplished business executive who has decades of experience driving profitable growth for healthcare entities. As a member of ...
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today participation in the National Institutes of Health (NIH) Intramural Research Program-sponsored study titled “An Observational Study of Neurologic Function after COVID-19 Infection” utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology. The study is ...
Vertex grant to JDRF supports efforts to improve clinical trial diversity in type 1 diabetes The Vertex Foundation grant supports the Mass General Comprehensive Sickle Cell Disease Treatment Center Additional Vertex Foundation grant to Year Up to support health care workforce training Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex and the Vertex Foundation, ...
DOYLESTOWN, PA / ACCESSWIRE / April 6, 2022 / Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB:NPTX), a socially responsible pain management life sciences company, announced today that its CEO Dean Petkanas has issued a letter to its shareholders, providing commentary on the Company’s recently achieved milestones, updates on its research and financial ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has commenced a Phase 2 clinical program for its third-generationiLink™ therapy designed to treat keratoconus. ...
Varadarajulu, MD, President, Orlando Health Digestive Health Institute. “We have designed a truly unique program.” “Omega is excited to be part of Orlando Health’s new state-of-the-art digestive health program,” said President and CEO of Omega Medical Imaging. ...
Imbed Biosciences Inc. (Imbed), a developer of next-generation therapies for tissue repair, and Spartan Medical, a veteran-owned Federal Contractor with fourteen years of flawless performance, jointly announced today that Imbed’s Microlyte® Matrix wound dressing portfolio has been added to Spartan Medical’s VA IDIQ Contract with the U.S. Department of Veteran Affairs (VA). The ...
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Department of Defense (DoD). The funds will be used to develop a rapid, quantitative, multiplexed test for ...
Novant Health’s integration of Aidoc’s AI solutions, amid the latest wave of the Omicron variant, expands upon its existing slate of innovative technologies designed to improve delivery of patient care and outcomes Aidoc, the leading provider of enterprise-grade AI solutions for medical imaging, announces a partnership with Novant Health, a health network of over 1,800 physicians ...
ByAidoc
OTTAWA, ON, Dec. 21, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the closing of its marketed public offering (the "Offering") of 13,064,000 units of the Company (the "Units"), at a price of $0.163 per Unit for aggregate gross proceeds of $2.1 ...
Rapidly growing teleradiology provider demonstrates safety and quality of care as company addresses global shortage of radiologists NEVE ILAN, Israel--(BUSINESS WIRE)--Dec. 15, 2021-- NANO-X IMAGING LTD. (“Nanox,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., one of the world’s leading ...